Discover more insights into Osteoporosis Drug

Keywords frequently search together with Osteoporosis Drug

Narrow sentence examples with built-in keyword filters

Osteoporosis Drug sentence examples within Term Osteoporosis Drug



REPORT ON SYSTEMATIC EVIDENCE REVIEW



Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review


Osteoporosis Drug sentence examples within Specific Osteoporosis Drug



[Influence of specific osteoporosis drugs on fracture healing].



Einfluss spezifischer Osteoporosemedikamente auf die Frakturheilung


Osteoporosis Drug sentence examples within Receive Osteoporosis Drug



Обізнаність жінок у постменопаузальному періоді про розвиток ризику остеопорозу (огляд літератури)



French Recommendations on Strategies for Preventing and Treating Osteoporosis Induced by Adjuvant Breast Cancer Therapies.




Osteoporosis Drug sentence examples within Several Osteoporosis Drug



Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients



Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention


Osteoporosis Drug sentence examples within Anabolic Osteoporosis Drug



Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis



Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss


Osteoporosis Drug sentence examples within osteoporosis drug treatment



Evaluation of quality and readability of online patient information on osteoporosis and osteoporosis drug treatment and recommendations for improvement



Can We Pave the Pathway to Fracture Prevention?


Osteoporosis Drug sentence examples within osteoporosis drug therapy



POS1116 ENHANCING OSTEOPOROSIS MANAGEMENT: THE CONTRIBUTION OF FRAX® AND VFA IN TUNISIAN WOMEN



Обізнаність жінок у постменопаузальному періоді про розвиток ризику остеопорозу (огляд літератури)


Osteoporosis Drug sentence examples within osteoporosis drug discovery



Therapeutic Potential, Synthesis, Patent evaluation and SAR studies of thieno[3,2-d]pyrimidine derivatives: Recent updates.



Dual Targeting of Bile Acid Receptor‐1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen‐Dependent Bone Loss in Mice


Osteoporosis Drug sentence examples within osteoporosis drug effect



Fracture outcome definitions in observational osteoporosis drug effects studies: a scoping review protocol.



Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes


Osteoporosis Drug sentence examples within osteoporosis drug development



Synthesis and Evaluation of Galloyl Conjugates of Flavanones as BMP-2 Upregulators with Promising Bone Anabolic and Fracture Healing Properties.



In vivo monitoring and high-resolution characterizing of the prednisolone-induced osteoporotic process on adult zebrafish by optical coherence tomography.


More Osteoporosis Drug sentence examples
10.1016/j.numecd.2021.01.019

Bone fragility in patients with diabetes mellitus: A consensus statement from the working group of the Italian Diabetes Society (SID), Italian Society of Endocrinology (SIE), Italian Society of Gerontology and Geriatrics (SIGG), Italian Society of Orthopaedics and Traumatology (SIOT).


More Osteoporosis Drug sentence examples
10.1007/s00198-021-06102-2

Long-term persistence with denosumab: real-world data from the Austrian Osteoporosis Clinic (AOC). A retrospective data analysis



The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment


More Osteoporosis Drug sentence examples
10.21203/RS.3.RS-181773/V1

A Systematic Review of the Relationship between Normal Range of Serum Thyroid-stimulating Hormone and Bone Mineral Density in the Postmenopausal Women


More Osteoporosis Drug sentence examples
10.1016/J.CHMED.2021.06.001

Systems pharmacology dissection of action mechanisms for herbs in osteoporosis treatment


More Osteoporosis Drug sentence examples
10.3389/fendo.2021.688269

The Effect of Bisphosphonates on Fracture Healing Time and Changes in Bone Mass Density: A Meta-Analysis


More Osteoporosis Drug sentence examples
10.1186/s13018-021-02678-x

Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis


More Osteoporosis Drug sentence examples
10.3389/fendo.2021.602221

Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China


More Osteoporosis Drug sentence examples
10.4028/www.scientific.net/AST.105.42

Fabrication of Chemically Linked PEGylated Prodrugs for Hydrogel Carriers


More Osteoporosis Drug sentence examples
10.1016/j.bcp.2021.114734

Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-κB signaling pathway.


More Osteoporosis Drug sentence examples
10.21203/RS.3.RS-346453/V1

Strontium Ranelate Promotes Chondrogenesis Through Inhibition of the Wnt/β-catenin Pathway


More Osteoporosis Drug sentence examples
10.1007/s41999-021-00493-5

Mastering the complexity: drug therapy optimization in geriatric patients



Recent development of drugs for osteoporosis and anti-cancer agents: a patent analysis.


More Osteoporosis Drug sentence examples
10.1097/GME.0000000000001756

The association between primary ovarian insufficiency and osteoporosis in the Canadian Longitudinal Study on Aging


More Osteoporosis Drug sentence examples
10.1016/j.actbio.2021.02.011

Interplay between Mineral Crystallinity and Mineral Accumulation in Health and Postmenopausal Osteoporosis.


More Osteoporosis Drug sentence examples
10.1136/bmjopen-2020-039238

Risk factors for new chronic opioid use after hip fracture surgery: a Danish nationwide cohort study from 2005 to 2016 using the Danish multidisciplinary hip fracture registry


More Osteoporosis Drug sentence examples
10.1007/s00198-021-05982-8

Fracture liaison services: past, present and future


More Osteoporosis Drug sentence examples
10.1053/j.ajkd.2021.06.031

Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review.


More Osteoporosis Drug sentence examples
10.1080/17446651.2021.1956902

Risks vs. benefits of switching therapy in patients with postmenopausal osteoporosis


More Osteoporosis Drug sentence examples
10.1016/J.MATDES.2021.109753

Functionalized anti-osteoporosis drug delivery system enhances osseointegration of an inorganic–organic bioactive interface in osteoporotic microenvironment



Anti-Osteoporosis Drugs for Overall Mortality in the Old (Ages ≥ 50 Years) and Oldest-Old (Ages ≥ 75): A Systematic Review and Meta-Analysis


More Osteoporosis Drug sentence examples
10.15625/2525-2518/59/4/15825

SCREENING FOR VIETNAMESE PLANT EXTRACTS WITH POTENTIAL BENEFIT FOR ANTI OSTEOCLASTOGENESISH


More Osteoporosis Drug sentence examples
10.1177/10499091211003078

Deprescribing in Older Adults With Cancer and Limited Life Expectancy: An Integrative Review.


More Osteoporosis Drug sentence examples
10.1186/s13287-021-02372-z

Strontium ranelate promotes chondrogenesis through inhibition of the Wnt/-catenin pathway


More Osteoporosis Drug sentence examples
10.1016/j.jjcc.2021.05.014

Impact of osteogenic activity on degenerative aortic valve disease in patients with osteoporotic hip fracture.



Amelioration of diabetes‐induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein‐7



Correlation Analysis of Adverse Reactions of Antiosteoporosis Drugs by Different Mechanisms with Bone Turnover and Vitamin D


More Osteoporosis Drug sentence examples
10.1007/s12020-021-02735-9

A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease



Factors Affecting Periprosthetic Bone Loss after Hip Arthroplasty


More Osteoporosis Drug sentence examples
10.36076/ppj.2021.24.e493

Evaluation of the Use of CT Attenuation for the Prediction of Subsequent Vertebral Fracture in Patients with Osteoporosis.


More Osteoporosis Drug sentence examples
10.1007/s00198-021-06067-2

No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study


More Osteoporosis Drug sentence examples
10.1016/J.JOGC.2021.02.065

The association of primary ovarian insufficiency, early menopause and osteoporosis in the canadian longitudinal study on aging


More Osteoporosis Drug sentence examples
10.1016/j.jpba.2020.113888

An UHPLC-MS/MS method for simultaneous determination of ten sex steroid hormones in ovariectomy-induced osteoporosis rat and its application in discovery of sex steroid hormones regulatory components of Xian-Ling-Gu-Bao capsule.


More Osteoporosis Drug sentence examples
10.11620/IJOB.2019.44.1.1

Biological characteristics of osteoporosis drugs: the effect of osteoblast–osteoclast coupling


More Osteoporosis Drug sentence examples
10.1007/s00393-019-00719-9

[Osteoporosis: long-term treatment versus drug holiday-what is the evidence?]


More Osteoporosis Drug sentence examples
10.1007/s00198-019-05164-7

Calcifediol or vitamin D to optimize vitamin D status: Reply to letter of M Sosas


More Osteoporosis Drug sentence examples
10.1302/2058-5241.4.180018

Molecular understanding of pharmacological treatment of osteoporosis


More Osteoporosis Drug sentence examples
10.1136/ANNRHEUMDIS-2019-EULAR.808

FRI0467 THE DISTRIBUTION OF PREVALENT AND INCIDENT VERTEBRAL FRACTURES IN THE TERIPARATIDE VERSUS RISEDRONATE “VERO” CLINICAL TRIAL


More Osteoporosis Drug sentence examples
10.3389/fphar.2019.00768

Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015


More Osteoporosis Drug sentence examples
10.1177/2042098619838138

Bisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy


More Osteoporosis Drug sentence examples
10.3760/CMA.J.ISSN.1673-4149.2019.06.012

Safety of clinical intervention on patients with hepatitis B cirrhosis-related osteoporosis



What Else Do We Need? A Commentary on Zoledronate Effects on Cancer and Cardiac Events


More Osteoporosis Drug sentence examples
10.1016/j.eclinm.2019.07.002

Bisphosphonates for Prevention of Bone Loss in Glucocorticoid-Treated Young People


More Osteoporosis Drug sentence examples
10.1021/acs.jmedchem.9b00932

Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of Osteoporosis.


More Osteoporosis Drug sentence examples
10.1016/j.mtchem.2019.08.008

Pentapeptide-decorated silica nanoparticles loading salmon calcitonin for in vivo osteoporosis treatment with sustained hypocalcemic effect


More Osteoporosis Drug sentence examples
10.1016/j.bone.2019.115125

Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: a practice-level prescribing data analysis in 2013-2018.


More Osteoporosis Drug sentence examples
10.1248/yakushi.18-00154-2

[A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation].


More Osteoporosis Drug sentence examples
10.1152/ajpendo.00343.2018

Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.


More Osteoporosis Drug sentence examples
10.1007/s00198-019-05064-w

Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom


More Osteoporosis Drug sentence examples
10.1007/s00198-019-05173-6

Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data


More Osteoporosis Drug sentence examples
10.1016/j.bone.2018.12.016

Hip fracture rates and time trends in use of anti-osteoporosis medications in Denmark for the period 2005 to 2015: Missed opportunities in fracture prevention.



Morphological profile of atypical femoral fractures: age‐related changes to the cross‐sectional geometry of the diaphysis



Osteoblast-derived NOTUM reduces cortical bone mass in mice and the NOTUM locus is associated with bone mineral density in humans


More Osteoporosis Drug sentence examples
10.1007/s00198-019-05154-9

Understanding patients’ preferences for osteoporosis treatment: the impact of patients’ characteristics on subgroups and latent classes


More Osteoporosis Drug sentence examples
10.1186/s12877-019-1064-8

Drug use differs by care level. A cross-sectional comparison between older people living at home or in a nursing home in Oslo, Norway


More Osteoporosis Drug sentence examples
10.1007/s00774-019-01061-5

Budget impact analysis of osteoporosis medications for primary prevention of fractures in Taiwan


More Osteoporosis Drug sentence examples
10.1016/j.mehy.2019.109427

Moderate osteoporosis itself is beneficial for bones.


More Osteoporosis Drug sentence examples
10.1590/1413-785220192702214727

PROFILE OF PATIENTS WITH OSTEOPOROTIC FRACTURES AND FACTORS THAT DECREASE PREVENTION


More Osteoporosis Drug sentence examples
10.1186/s13018-019-1499-9

Therapeutic effect of percutaneous kyphoplasty combined with anti-osteoporosis drug on postmenopausal women with osteoporotic vertebral compression fracture and analysis of postoperative bone cement leakage risk factors: a retrospective cohort study



Osteoporosis Drug
Encyclopedia